INSIGHT - Third Quarter 2019

3rd QTR 2019 | 8 Follow Us. We Know t NCPDP New SCRIPT Standard Crystal Ratliff, CPM, PhT, Vendor Relations Product Manager Who remembers Y2K? I remember wondering if once the ball dropped at midnight, our economy, infrastructure, or some other important system would be crippled or rendered irreparable. Well, even though CMS mandated a new electronic prescribing standard with a hard-cutover date of January 1, 2020, there’s no need to worry this New Year’s Eve. That’s right, as of January 1, all electronic prescriptions for Medicare Part D-eligible patients will need to be sent using the new ePrescribing standard, NCPDP SCRIPT version 2017071. And QS/1 is ready! Having completed our certifications, we’re working every day to test and design rollout plans to ensure your pharmacy can begin implementing the new version when you’re ready. Version 2017071 provides many new fields and message types that can help streamline pharmacy workflow and improve overall patient safety, and since it has taken the industry working together for nine years to get here, it should be good! The only caveat to this great new functionality is some of the new fields and transaction types are optional, and as you can imagine, prescriber software and pharmacy software have different priorities. But we’re working with all the players across the industry to advocate for tools and functionality that further increase patient safety and provide even greater efficiency for community pharmacies. The Details Let’s dive into the details and discover the tools your pharmacy will be most interested in. First, QS/1 had to be prepared to update the existing SCRIPT version 10.6 message types to use the new version. The message types available today are: NewRx, Refill Request and Refill Response (now known as Renewal Request/ Response), and CancelRx. NewRx is the most commonly used message type, and it allows the prescriber to send a prescription electronically to the pharmacy. This may or may not include electronic prescriptions for controlled substances (EPCS) since it varies by prescribing system and whether the prescriber is using EPCS. Many fields were added to the new version that will better inform the pharmacy upon receiving and filling electronic prescriptions. Fields like Former Name (i.e., maiden name) were added to both the Patient and Prescriber, which helps the pharmacy ensure it’s selecting the right patient or prescriber from its database. The biggest change most pharmacies are looking forward to is the ability to receive allergies within the NewRx from the prescriber. There is still much discussion about identifying best practices for patient allergies and determining whether the EHR or the pharmacy management system is the system of truth when it comes to having allergies on file. However, this will allow the information to be sent to the pharmacy for greater awareness. An Urgency Indicator was added to both the NewRx from the prescriber and the Renewal Request from the pharmacy to allow the sender to indicate the request should be expedited. Understandably, there is some skepticism that the Urgency Indicator will be misused but having a way to expedite prescriptions allows the software systems to build in tools to process those prescriptions first. Many fields were added to the prescriber segment to provide better identification across multiple places of service but also to include identifiers (e.g., NADEAN) that haven’t had an explicit spot in the standard before now. One of the changes to the prescriber section that may take some time to get used to is Prohibit Renewal Requests and Follow Up Prescriber. If a patient visits an emergency room and the prescriber writes a prescription but wants the patient to follow up with the primary care provider (PCP), he will send Prohibit Renewal Requests as Y, indicating he should not be contacted for additional refills. Follow Up Prescriber indicates the patient’s PCP for follow up. Individual message types were added to the Directory updates for prescribers, so the pharmacy can easily indicate which message types are enabled for participating prescribers.